GROWTH VERSE Co., Ltd.
PrivateLast Round
Series C
Jul 9, 2025
Est. Valuation
$70.88M
Total Funding Raised
$46.6M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
GROWTH VERSE Co., Ltd. operates in Enterprise Software and is based in Tokyo. Its latest recorded funding round was a Series C round in July 2025.
GROWTH VERSE Co., Ltd. is an AI SaaS company that provides a platform of AI agents for marketing, people flow analysis, and sales management to maximize business growth.
Sector
Enterprise Software
Verticals
Marketing, Retail Technology, CRM, NLP & Conversational AI, Business Intelligence
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GROWTH VERSE Co., Ltd. Comparables
Compare GROWTH VERSE Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Data X | 83% | |
| PLAID, Inc. | 83% | |
| Repro Inc. | 78% |
For institutional investors. Book with your work email.
GROWTH VERSE Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 9, 2025 | ||||
| Debt | Jul 9, 2025 | ||||
| Series B | Mar 14, 2025 | ||||
| Series A Extension | Aug 26, 2024 | ||||
| Series A | Jun 30, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GROWTH VERSE Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| THE GOGIN CAPITAL Co., Ltd. | Series C, Series B |
| Neoteny | Series C |
| Mizuho Capital | Series C |
| BIPROGY | Series B |
| Chugin Capital Partners | Series C |
| TNBI | Series A |
| Chibagin Capital | Series C |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 24, 2026
Grew 17% QoQ, from 35 to 41 employees.
- Aug 1, 2026
Job posting mentions the company co-hosted the 'golang.tokyo #44' event in August 2026.
For institutional investors. Book with your work email.
GROWTH VERSE Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GROWTH VERSE Co., Ltd.'s valuation, stock price, and market status.
Is GROWTH VERSE Co., Ltd. a public or private company?
GROWTH VERSE Co., Ltd. is a private company.
What is the current stock price of GROWTH VERSE Co., Ltd.?
GROWTH VERSE Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks GROWTH VERSE Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GROWTH VERSE Co., Ltd. worth (valuation)?
GROWTH VERSE Co., Ltd.'s valuation is estimated at $70.9M based on funding round data.
Can I buy GROWTH VERSE Co., Ltd. stock?
GROWTH VERSE Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GROWTH VERSE Co., Ltd.'s last funding round?
GROWTH VERSE Co., Ltd.'s most recent funding round was Series C on July 9, 2025.
Who are the main investors in GROWTH VERSE Co., Ltd.?
Key investors in GROWTH VERSE Co., Ltd. include THE GOGIN CAPITAL Co., Ltd., Neoteny, Mizuho Capital, BIPROGY, Chugin Capital Partners.
Will GROWTH VERSE Co., Ltd. IPO soon?
No public IPO plans have been announced for GROWTH VERSE Co., Ltd..
How can I track GROWTH VERSE Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in GROWTH VERSE Co., Ltd.'s shares on secondary markets.